-
| ISIN | CNE100003Y57 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | 2.43 |
|---|---|
| Market Cap | 7B |
| PE Ratio | 25.92 |
| Target Price | 64 |
| Dividend Yield | None |
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300841.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025